IL134505A0 - Coding sequence haplotypes of the human brca2 gene - Google Patents

Coding sequence haplotypes of the human brca2 gene

Info

Publication number
IL134505A0
IL134505A0 IL13450598A IL13450598A IL134505A0 IL 134505 A0 IL134505 A0 IL 134505A0 IL 13450598 A IL13450598 A IL 13450598A IL 13450598 A IL13450598 A IL 13450598A IL 134505 A0 IL134505 A0 IL 134505A0
Authority
IL
Israel
Prior art keywords
coding sequence
brca2 gene
human brca2
sequence haplotypes
haplotypes
Prior art date
Application number
IL13450598A
Other languages
English (en)
Original Assignee
Oncormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncormed Inc filed Critical Oncormed Inc
Publication of IL134505A0 publication Critical patent/IL134505A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2539/00—Reactions characterised by analysis of gene expression or genome comparison
    • C12Q2539/10—The purpose being sequence identification by analysis of gene expression or genome comparison characterised by
    • C12Q2539/105—Involving introns, exons, or splice junctions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13450598A 1997-08-15 1998-08-14 Coding sequence haplotypes of the human brca2 gene IL134505A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US5578497P 1997-08-15 1997-08-15
US6492697P 1997-11-07 1997-11-07
US6536797P 1997-11-12 1997-11-12
US7171598A 1998-05-01 1998-05-01
US8447198A 1998-05-22 1998-05-22
PCT/US1998/016905 WO1999009164A1 (fr) 1997-08-15 1998-08-14 Haplotypes d'une sequence codante du gene humain brca2

Publications (1)

Publication Number Publication Date
IL134505A0 true IL134505A0 (en) 2001-04-30

Family

ID=27535329

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13450598A IL134505A0 (en) 1997-08-15 1998-08-14 Coding sequence haplotypes of the human brca2 gene

Country Status (5)

Country Link
EP (3) EP2275574B1 (fr)
JP (3) JP2001514887A (fr)
AU (1) AU9292898A (fr)
IL (1) IL134505A0 (fr)
WO (1) WO1999009164A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051379A (en) * 1997-09-23 2000-04-18 Oncormed, Inc. Cancer susceptibility mutations of BRCA2
US7807447B1 (en) 2000-08-25 2010-10-05 Merck Sharp & Dohme Corp. Compositions and methods for exon profiling
US6713257B2 (en) 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5593840A (en) 1993-01-27 1997-01-14 Oncor, Inc. Amplification of nucleic acid sequences
WO1997019110A1 (fr) * 1995-11-23 1997-05-29 Cancer Research Campaign Technology Limited Materiaux et procedes relatifs a l'identification et au sequençagge du gene de susceptibilite brca2 du cancer et ses utilisations
GB2307477B (en) * 1995-11-23 1997-10-22 Cancer Res Campaign Tech Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
IL124620A0 (en) * 1995-12-18 1998-12-06 Myriad Genetics Inc Chromosome 13-linked breast cancer susceptibility gene
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins

Also Published As

Publication number Publication date
EP2275574A2 (fr) 2011-01-19
EP2275575A2 (fr) 2011-01-19
EP2275574B1 (fr) 2015-06-03
WO1999009164A1 (fr) 1999-02-25
JP2013143958A (ja) 2013-07-25
WO1999009164A9 (fr) 1999-05-06
JP2009118863A (ja) 2009-06-04
AU9292898A (en) 1999-03-08
JP2001514887A (ja) 2001-09-18
EP2275574A3 (fr) 2012-06-27
EP2275575A3 (fr) 2012-07-11
EP0994946A1 (fr) 2000-04-26

Similar Documents

Publication Publication Date Title
GB9622500D0 (en) Therapeutic gene
PL340255A1 (en) Non-dissolving insulin compositions
EP1006186A4 (fr) Genes humains
EP0889055A4 (fr) Acide hyaluronique oligosulfate
EG21712A (en) Treatment of insulin resistance
EP1077996A4 (fr) GENE EDG3sb HUMAIN
GB9700899D0 (en) Novel treatment
SG68001A1 (en) Silicone rubber composite
GB9506470D0 (en) 5b4t coding scheme
GB9700939D0 (en) Therapy
PL340584A1 (en) Medical spatula
IL134505A0 (en) Coding sequence haplotypes of the human brca2 gene
AU132496S (en) Personal digital assistant
AU1541399A (en) Human nucleotide pyrophosphohydrolase-2
EP0958304A4 (fr) Sequence nucleotidique codant la proteine de type cd33
AU9321698A (en) Susceptibility mutation 6495delgc of brca2
AU9034498A (en) Human nucleotide pyrophosphohydrolase
GB0014599D0 (en) Coding scheme
PL336906A1 (en) Reduction of aromatic halides
GB9721692D0 (en) Novel treatment
GB9721693D0 (en) Novel treatment
GB2333527B (en) Therapeutic gene
GB9714742D0 (en) Medical cement
PL318841A1 (en) Electrolyser
HUP9902845A3 (en) Novel treatment of leptine resistance